FDA Inspection 1201277 — Medpace Core Laboratories, LLC

Medpace Core Laboratories, LLC — FEI 3005524314

The FDA completed an inspection of Medpace Core Laboratories, LLC on Mar 23, 2023 in Cincinnati, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 23, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cincinnati, OH (United States)

Additional details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.